These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. [Indications for implantable automatic defibrillators]. Leenhardt A, Coumel P, Thomas O, Leclercq JF, Slama R. Arch Mal Coeur Vaiss; 1994 Jan; 87(1 Spec No):61-6. PubMed ID: 7944867 [Abstract] [Full Text] [Related]
6. The Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial: rationale, design, results, clinical implications and lessons for future trials. Wilkoff BL, Dual Chamber and VVI Implantable Defibrillator trial investigators. Card Electrophysiol Rev; 2003 Dec; 7(4):468-72. PubMed ID: 15071277 [Abstract] [Full Text] [Related]
7. [Implantable defibrillator. Update]. Maury P, Schläpfer J, Metzger J, Delacrétaz E, Fromer M, Kappenberger L. Rev Med Suisse Romande; 2001 Apr; 121(4):319-25. PubMed ID: 11400406 [Abstract] [Full Text] [Related]
8. [Observations on the implantable automatic defibrillator]. Slama R. Bull Mem Acad R Med Belg; 1994 Apr; 149(8-11):383-7; discussion 387-8. PubMed ID: 7550040 [Abstract] [Full Text] [Related]
11. Inductionless or limited shock testing is possible in most patients with implantable cardioverter- defibrillators/cardiac resynchronization therapy defibrillators: results of the multicenter ASSURE Study (Arrhythmia Single Shock Defibrillation Threshold Testing Versus Upper Limit of Vulnerability: Risk Reduction Evaluation With Implantable Cardioverter-Defibrillator Implantations). Day JD, Doshi RN, Belott P, Birgersdotter-Green U, Behboodikhah M, Ott P, Glatter KA, Tobias S, Frumin H, Lee BK, Merillat J, Wiener I, Wang S, Grogin H, Chun S, Patrawalla R, Crandall B, Osborn JS, Weiss JP, Lappe DL, Neuman S. Circulation; 2007 May 08; 115(18):2382-9. PubMed ID: 17470697 [Abstract] [Full Text] [Related]
12. Infarct tissue heterogeneity assessed with contrast-enhanced MRI predicts spontaneous ventricular arrhythmia in patients with ischemic cardiomyopathy and implantable cardioverter-defibrillator. Roes SD, Borleffs CJ, van der Geest RJ, Westenberg JJ, Marsan NA, Kaandorp TA, Reiber JH, Zeppenfeld K, Lamb HJ, de Roos A, Schalij MJ, Bax JJ. Circ Cardiovasc Imaging; 2009 May 08; 2(3):183-90. PubMed ID: 19808591 [Abstract] [Full Text] [Related]
13. Indications for ICD and cardiac resynchronization therapy for prevention of sudden cardiac death. Das M. Expert Rev Cardiovasc Ther; 2009 Feb 08; 7(2):181-95. PubMed ID: 19210214 [Abstract] [Full Text] [Related]
16. Recurrence of ventricular arrhythmias in ischaemic secondary prevention implantable cardioverter defibrillator recipients: long-term follow-up of the Leiden out-of-hospital cardiac arrest study (LOHCAT). Borleffs CJ, van Erven L, Schotman M, Boersma E, Kiès P, van der Burg AE, Zeppenfeld K, Bootsma M, van der Wall EE, Bax JJ, Schalij MJ. Eur Heart J; 2009 Jul 08; 30(13):1621-6. PubMed ID: 19493865 [Abstract] [Full Text] [Related]
18. Sudden cardiac death and channelopathies: a review of implantable defibrillator therapy. Choi GR, Porter CB, Ackerman MJ. Pediatr Clin North Am; 2004 Oct 08; 51(5):1289-303. PubMed ID: 15331285 [Abstract] [Full Text] [Related]